tyvaso.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
User-agent: * Disallow: *.pdf Sitemap: | ||
Meta Tags
| Title | TYVASO® (treprostinil) Inhalation Solution and TYVASO DPI® (treprostinil) Inhalation Powder | for |
| Description | Learn how TYVASO may Patient website for TYVASO® and TYVASO DPI®, inhaled treatments approved for the treatment of PAH and |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 45.60.45.59 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
tyvaso.com Valuation
|
US$35,955,170
Last updated: 2023-04-27 05:19:30
tyvaso.com has Semrush global rank of 294,375. tyvaso.com has an estimated worth of US$ 35,955,170, based on its estimated Ads revenue. tyvaso.com receives approximately 4,148,674 unique visitors each day. Its web server is located in United States, with IP address 45.60.45.59. According to SiteAdvisor, tyvaso.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$35,955,170 |
| Daily Ads Revenue | US$33,190 |
| Monthly Ads Revenue | US$995,682 |
| Yearly Ads Revenue | US$11,948,180 |
| Daily Unique Visitors | 276,579 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| tyvaso.com. | A | 3599 | IP: 45.60.45.59 |
| tyvaso.com. | A | 3599 | IP: 45.60.106.59 |
| tyvaso.com. | NS | 86400 | NS Record: ns6.markmonitor.com. |
| tyvaso.com. | NS | 86400 | NS Record: ns1.markmonitor.com. |
| tyvaso.com. | NS | 86400 | NS Record: ns5.markmonitor.com. |
| tyvaso.com. | NS | 86400 | NS Record: ns3.markmonitor.com. |
| tyvaso.com. | NS | 86400 | NS Record: ns4.markmonitor.com. |
| tyvaso.com. | NS | 86400 | NS Record: ns7.markmonitor.com. |
| tyvaso.com. | NS | 86400 | NS Record: ns2.markmonitor.com. |
| tyvaso.com. | MX | 3600 | MX Record: 0 aws1.progsupport.net. |
| tyvaso.com. | TXT | 3600 | TXT Record: _globalsign-domain-verification=jwNPSChHcrfkXDIUlz9Y7-OAgzz_3kFwSQE1BQGjf8 |
| tyvaso.com. | TXT | 3600 | TXT Record: zm668gskfgrhl5c9c05h2r2z77h50f73 |
| tyvaso.com. | TXT | 3600 | TXT Record: v=spf1 a mx ip4:208.109.119.9 include:aws1.progsupport.net -all |
| tyvaso.com. | TXT | 3600 | TXT Record: google-site-verification=bFNv9n1bdZkVXgCQEbPrM64MWCT1FHNawZBzPHJwpHA |
| tyvaso.com. | TXT | 3600 | TXT Record: _globalsign-domain-verification=NdEH4Kgd6I-3o0PKyC9VM5KNSBtVQx0Vz_U75C8WZq |
| tyvaso.com. | TXT | 3600 | TXT Record: facebook-domain-verification=5gtbetauhlhrht0xkz5vk8wlgxkeia |
| tyvaso.com. | TXT | 3600 | TXT Record: app-tyvaso.azurewebsites.net |
| tyvaso.com. | TXT | 3600 | TXT Record: _globalsign-domain-verification=wTK_NeIvGxUM5NustAuZOe1h5AD2tnoaL0PD869hfF |
HtmlToTextCheckTime:2023-04-27 05:19:30
| Important Safety Information Prescribing Information TYVASO TYVASO DPI Instructions for Use TYVASO TYVASO DPI The information contained in this section of the site is clinical in nature and specifically created for healthcare professionals. If you are not a US healthcare professional, please click CLOSE to return to the consumer section of the site. Close Yes, I am a US healthcare professional and would like to continue. Continue For US Healthcare Professionals SELECT A CONDITION PH-ILD (WHO GROUP 3) PAH (WHO GROUP 1) TYVASO and TYVASO DPI are approved for the treatment of pulmonary arterial hypertension (PAH; WHO Group 1) and pulmonary hypertension associated with interstitial lung disease ( PH-ILD ; WHO Group 3) to improve the ability to exercise. SELECT A CONDITION PH-ILD (WHO GROUP 3) PAH (WHO GROUP 1) Learn how TYVASO may help TYVASO for PH-ILD (WHO Group 3) Pulmonary hypertension associated with interstitial lung disease TYVASO for PAH (WHO Group 1) Pulmonary arterial |
HTTP Headers
HTTP/1.1 301 Moved Permanently Location: https://tyvaso.com/ Content-Length: 0 Connection: close HTTP/2 308 location: https://www.tyvaso.com/ content-length: 0 strict-transport-security: max-age=31536000; includeSubDomains; preload HTTP/2 200 cache-control: max-age=600 content-length: 560585 content-type: text/html expires: Wed, 20 Oct 2021 11:41:04 GMT last-modified: Thu, 09 Sep 2021 14:42:14 GMT accept-ranges: bytes etag: "88dc9-5cb910132c37e" vary: Accept-Encoding server: Apache strict-transport-security: max-age=31536000;includeSubDomains; x-frame-options: SAMEORIGIN x-xss-protection: 1; mode=block x-content-type-options: nosniff date: Wed, 20 Oct 2021 11:31:04 GMT set-cookie: visid_incap_2097700=s6cOhMHiSHeFYWUPMXqBLfj9b2EAAAAAQUIPAAAAAABNNiQC4H1vDHxfTjeZ7FKf; expires=Thu, 20 Oct 2022 09:32:18 GMT; HttpOnly; path=/; Domain=.tyvaso.com; Secure; SameSite=None set-cookie: nlbi_2097700=XLZTEtZgIEj9nqXxv2oAsAAAAAC0KETAB5BnWv8viqs80+KS; path=/; Domain=.tyvaso.com; Secure; SameSite=None set-cookie: incap_ses_7221_2097700=Qj/SPwtFwAmwpCsAjSU2ZPj9b2EAAAAAvTewgoeydtkSzOYUGUGM8A==; path=/; Domain=.tyvaso.com; Secure; SameSite=None x-cdn: Imperva x-iinfo: 6-9867774-9867775 NNNN CT(27 59 0) RT(1634729464551 0) q(0 0 1 0) r(2 2) U12 |
tyvaso.com Whois Information
Domain Name: TYVASO.COM Registry Domain ID: 1484097386_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.markmonitor.com Registrar URL: http://www.markmonitor.com Updated Date: 2021-04-29T09:42:40Z Creation Date: 2008-05-31T19:26:12Z Registry Expiry Date: 2023-05-31T19:26:12Z Registrar: MarkMonitor Inc. Registrar IANA ID: 292 Registrar Abuse Contact Email: abusecomplaints@markmonitor.com Registrar Abuse Contact Phone: +1.2083895740 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS1.MARKMONITOR.COM Name Server: NS2.MARKMONITOR.COM Name Server: NS3.MARKMONITOR.COM Name Server: NS4.MARKMONITOR.COM Name Server: NS5.MARKMONITOR.COM Name Server: NS6.MARKMONITOR.COM Name Server: NS7.MARKMONITOR.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-09T00:26:56Z <<< |